KPIs & Operating Metrics(New)
Balance Sheet
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Non-Current Deffered Revenue (2018 - 2024)

BioNTech SE's Non-Current Deffered Revenue history spans 7 years, with the latest figure at $195.6 million for Q4 2024.

  • For Q4 2024, Non-Current Deffered Revenue fell 54.39% year-over-year to $195.6 million; the TTM value through Dec 2024 reached $195.6 million, down 54.39%, while the annual FY2024 figure was $198.1 million, 54.05% down from the prior year.
  • Non-Current Deffered Revenue for Q4 2024 was $195.6 million at BioNTech SE, down from $428.8 million in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $428.8 million in Q4 2023 and bottomed at $10.3 million in Q4 2021.
  • The 5-year median for Non-Current Deffered Revenue is $85.7 million (2020), against an average of $153.9 million.
  • The largest annual shift saw Non-Current Deffered Revenue tumbled 87.99% in 2021 before it surged 768.29% in 2023.
  • A 5-year view of Non-Current Deffered Revenue shows it stood at $85.7 million in 2020, then tumbled by 87.99% to $10.3 million in 2021, then surged by 379.62% to $49.4 million in 2022, then soared by 768.29% to $428.8 million in 2023, then crashed by 54.39% to $195.6 million in 2024.
  • Per Business Quant, the three most recent readings for BNTX's Non-Current Deffered Revenue are $195.6 million (Q4 2024), $428.8 million (Q4 2023), and $49.4 million (Q4 2022).